Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 219 Carboplatin 218 Specimen Handling 196 Cisplatin 188 Magnetic Resonance Spectroscopy 167 Radiotherapy 152 Bevacizumab 142 Gemcitabine 135 Cyclophosphamide 133 Drug Therapy 118 Capecitabine 117 Paclitaxel 112 Oxaliplatin 110 Biopsy 105 venetoclax 102 Nivolumab 101 Rituximab 83 tislelizumab 81 durvalumab 81 toripalimab 77 Fluorouracil 73 Etoposide 72 Dexamethasone 69 sintilimab 67 Radiosurgery 67 Docetaxel 67 Pemetrexed 65 atezolizumab 64 Azacitidine 63 Injections 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × letermovir × Clear all

NCT06920251 2025-12-03

OPTIMUS-EL

Seoul National University Hospital

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡